HALBERT JON 4
4 · Caris Life Sciences, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
HALBERT JON
Director
Transactions
- Award
Common Stock
2025-02-27+16,129→ 116,129 total - Conversion
Common Stock
2025-06-20+1,250,000→ 1,250,000 total(indirect: By LLC) - Conversion
Series A Preferred Stock
2025-06-20−5,000,000→ 0 total(indirect: By LLC)Exercise: $0.00→ Common Stock (1,250,000 underlying)
Footnotes (3)
- [F1]Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. These restricted stock units were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025.
- [F2]Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock.
- [F3]The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.